BACKGROUND: Data to support improved patient outcomes from clinical decision-support systems (CDSSs) are lacking in HIV care. OBJECTIVE: To test the efficacy of a CDSS in improving HIV outcomes in an outpatient clinic. DESIGN: Randomized, controlled trial. (ClinicalTrials.gov registration number: NCT00678600) SETTING:Massachusetts General Hospital HIV Clinic. PARTICIPANTS: HIV care providers and their patients. INTERVENTION: Computer alerts were generated for virologic failure (HIV RNA level >400 copies/mL after a previous HIV RNA level ≤400 copies/mL), evidence of suboptimal follow-up, and 11 abnormal laboratory test results. Providers received interactive computer alerts, facilitating appointment rescheduling and repeated laboratory testing, for half of their patients and static alerts for the other half. MEASUREMENTS: The primary end point was change in CD4 cell count. Other end points included time to clinical event, 6-month suboptimal follow-up, and severe laboratory toxicity. RESULTS:Thirty-three HIV care providers followed 1011 patients with HIV. In the intervention group, the mean increase in CD4 cell count was greater (0.0053 vs. 0.0032 × 109 cells/L per month; difference, 0.0021 × 109 cells/L per month [95% CI, 0.0001 to 0.004]; P = 0.040) and the rate of 6-month suboptimal follow-up was lower (20.6 vs. 30.1 events per 100 patient-years; P = 0.022) than those in the control group. Median time to next scheduled appointment was shorter in the intervention group than in the control group after a suboptimal follow-up alert (1.71 vs. 3.48 months; P < 0.001) and after a toxicity alert (2.79 vs. >6 months; P = 0.072). More than 90% of providers supported adopting the CDSS as part of standard care. LIMITATION: This was a 1-year informatics study conducted at a single hospital subspecialty clinic. CONCLUSION: A CDSS using interactive provider alerts improved CD4 cell counts and clinic follow-up for patients with HIV. Wider implementation of such systems can provide important clinical benefits. PRIMARY FUNDING SOURCE: National Institute of Allergy and Infectious Diseases.
RCT Entities:
BACKGROUND: Data to support improved patient outcomes from clinical decision-support systems (CDSSs) are lacking in HIV care. OBJECTIVE: To test the efficacy of a CDSS in improving HIV outcomes in an outpatient clinic. DESIGN: Randomized, controlled trial. (ClinicalTrials.gov registration number: NCT00678600) SETTING: Massachusetts General Hospital HIV Clinic. PARTICIPANTS: HIV care providers and their patients. INTERVENTION: Computer alerts were generated for virologic failure (HIV RNA level >400 copies/mL after a previous HIV RNA level ≤400 copies/mL), evidence of suboptimal follow-up, and 11 abnormal laboratory test results. Providers received interactive computer alerts, facilitating appointment rescheduling and repeated laboratory testing, for half of their patients and static alerts for the other half. MEASUREMENTS: The primary end point was change in CD4 cell count. Other end points included time to clinical event, 6-month suboptimal follow-up, and severe laboratory toxicity. RESULTS: Thirty-three HIV care providers followed 1011 patients with HIV. In the intervention group, the mean increase in CD4 cell count was greater (0.0053 vs. 0.0032 × 109 cells/L per month; difference, 0.0021 × 109 cells/L per month [95% CI, 0.0001 to 0.004]; P = 0.040) and the rate of 6-month suboptimal follow-up was lower (20.6 vs. 30.1 events per 100 patient-years; P = 0.022) than those in the control group. Median time to next scheduled appointment was shorter in the intervention group than in the control group after a suboptimal follow-up alert (1.71 vs. 3.48 months; P < 0.001) and after a toxicity alert (2.79 vs. >6 months; P = 0.072). More than 90% of providers supported adopting the CDSS as part of standard care. LIMITATION: This was a 1-year informatics study conducted at a single hospital subspecialty clinic. CONCLUSION: A CDSS using interactive provider alerts improved CD4 cell counts and clinic follow-up for patients with HIV. Wider implementation of such systems can provide important clinical benefits. PRIMARY FUNDING SOURCE: National Institute of Allergy and Infectious Diseases.
Authors: Amit X Garg; Neill K J Adhikari; Heather McDonald; M Patricia Rosas-Arellano; P J Devereaux; Joseph Beyene; Justina Sam; R Brian Haynes Journal: JAMA Date: 2005-03-09 Impact factor: 56.272
Authors: Nidhi R Shah; Andrew C Seger; Diane L Seger; Julie M Fiskio; Gilad J Kuperman; Barry Blumenfeld; Elaine G Recklet; David W Bates; Tejal K Gandhi Journal: J Am Med Inform Assoc Date: 2005-10-12 Impact factor: 4.497
Authors: M Arnedo-Valero; F Garcia; C Gil; T Guila; E Fumero; P Castro; J L Blanco; J M Miró; T Pumarola; J M Gatell Journal: Clin Infect Dis Date: 2005-08-04 Impact factor: 9.079
Authors: A Mocroft; O Kirk; P Aldins; A Chies; A Blaxhult; N Chentsova; N Vetter; F Dabis; J Gatell; J D Lundgren Journal: HIV Med Date: 2008-05 Impact factor: 3.180
Authors: Nancy Puttkammer; Jane M Simoni; Tracy Sandifer; Jean Marcxime Chéry; Witson Dervis; Jean Gabriel Balan; Jean Geto Dubé; Guirlaine Calixte; Ermane Robin; Kesner François; Cameron Casey; Ira Wilson; Jean Guy Honoré Journal: AIDS Behav Date: 2020-12
Authors: Lorenzo Moja; Koren H Kwag; Theodore Lytras; Lorenzo Bertizzolo; Linn Brandt; Valentina Pecoraro; Giulio Rigon; Alberto Vaona; Francesca Ruggiero; Massimo Mangia; Alfonso Iorio; Ilkka Kunnamo; Stefanos Bonovas Journal: Am J Public Health Date: 2014-10-16 Impact factor: 9.308
Authors: Barbara S Taylor; Laura Fornos; Jesse Tarbutton; Jana Muñoz; Julie A Saber; Delia Bullock; Roberto Villarreal; Ank E Nijhawan Journal: AIDS Patient Care STDS Date: 2018-09 Impact factor: 5.078
Authors: Kathryn A Risher; Sunaina Kapoor; Alice Moji Daramola; Gabriela Paz-Bailey; Jacek Skarbinski; Kate Doyle; Kate Shearer; David Dowdy; Eli Rosenberg; Patrick Sullivan; Maunank Shah Journal: AIDS Behav Date: 2017-07
Authors: Elaine W Flagg; Hillard S Weinstock; Emma L Frazier; Eduardo E Valverde; James D Heffelfinger; Jacek Skarbinski Journal: Sex Transm Dis Date: 2015-04 Impact factor: 2.830
Authors: Emanuel Krebs; Xiao Zang; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Julia C Dombrowski; Daniel J Feaster; Kelly A Gebo; Brandon D L Marshall; Shruti H Mehta; Lisa R Metsch; Ankur Pandya; Bruce R Schackman; Steffanie A Strathdee; Bohdan Nosyk Journal: J Infect Dis Date: 2020-09-02 Impact factor: 5.226
Authors: Kaveh G Shojania; Alison Jennings; Alain Mayhew; Craig R Ramsay; Martin P Eccles; Jeremy Grimshaw Journal: Cochrane Database Syst Rev Date: 2009-07-08